| Aa | amino acids |
| ADC | antibody-drug conjugate |
| ADCC | antibody-dependant cell-mediated cytotoxicity |
| APO | apoptosis antigen |
| Bcl-2 | B-cell lymphoma 2, apoptosis inhibitor |
| BsAbs | bispecific antibodies |
| CARs | chimeric antibody receptors |
| CD | cluster of differentiation |
| CDC | complement-dependent cellular cytotoxicity |
| c-FLIP | cellular FLICE (FADD-like IL-1β-converting enzyme)-inhibitory protein |
| CPT-TRAIL | circularly permuted TRAIL |
| DC | dendritic cell |
| DcR | decoy receptor |
| DcR1 | decoy receptor 1, TRAIL-R3 |
| DcR2 | decoy receptor 2, TRAIL-R4 |
| DD | death domain |
| DISC | death-inducing signaling complex |
| DR | death receptor |
| DR4 | death receptor 4, TRAIL-R1 |
| DR5 | death receptor 5, TRAIL-R2 |
| Fab | fragment antigen-binding |
| Fas | fibroblast associated surface antigen |
| Fas-L | as ligand |
| Fc | crystalized fragment |
| FcR | crystalized fragment receptor |
| GPI | glycosylphosphatidylinisotol |
| KD | Kringle domain |
| Mcl-1 | myeloid cell leukemia-1 |
| moAbs | monoclonal antibodies |
| NK cell | natural killer cell |
| OPG | steoprotegerin, TRAIL-R5 |
| PBLs | eripheral blood cells |
| ROS | reactive oxygen species |
| rhTRAIL | human recombinant TRAIL |
| scFv | single chain fragment variable |
| sc-TRAIL | single chain TRAIL |
| sTRAIL | soluble TRAIL |
| TNC-TRAIL | tenascin-C-TRAIL |
| TNF | tumor necrosis factor |
| TNF-α | tumor necrosis factor alpha |
| TRAIL | TNF-related apoptosis-inducing ligand |